Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hasegawa H., FukushimaT., Lee JA., Tsukamotoc K., Moriyad K., Onoe Y. and Imai K.*
------>authors3_c=None
------>paper_class1=1
------>Impact_Factor=None
------>paper_class3=2
------>paper_class2=1
------>vol=377
------>confirm_bywho=kyhsu
------>insert_bywho=jenai
------>Jurnal_Rank=None
------>authors4_c=None
------>comm_author=
------>patent_EDate=None
------>authors5_c=None
------>publish_day=None
------>paper_class2Letter=None
------>page2=891
------>medlineContent=
------>unit=G0100
------>insert_date=20030908
------>iam=3
------>update_date=
------>author=???
------>change_event=5
------>ISSN=None
------>authors_c=None
------>score=479
------>journal_name=Anal. and Bioanal. Chem.
------>paper_name=Determination of serum D- and L-lactic acids in normal subjects and diabetic patients by column-switching HPLC with pre-column fluorescence derivatization
------>confirm_date=20031020
------>tch_id=089023
------>pmid=12879188
------>page1=886
------>fullAbstract=d-Lactic and l-lactic acids were simultaneously determined by means of a column-switching high-performance liquid chromatography (HPLC) with fluorescence detection. As a fluorescence reagent, 4-nitro-7-piperazino-2,1,3-benzoxadiazole (NBD-PZ) was employed for the fluorescence derivatization of lactic acid. The proposed HPLC system adopted both octylsilica (Cadenza CD-C8) and amylose-based chiral columns (CHIRALPAK AD-RH), which proved to give a sufficient enantiomeric separation of the lactic acid derivatives with a separation factor ( alpha) of 1.32 and a resolution ( R(s)) of 1.98. Moreover, the features of the first elution of d-lactic acid peak in the proposed HPLC were convenient for the determination of trace amount of serum d-lactic acid, which is known to increase under diabetes. Intra-day and inter-day accuracies were in the range of 90.5-101.2 and 89.0-100.7%, and the intra-day and inter-day precisions were 0.3-1.2 and 0.4-4.8%, respectively. The proposed method was applied to determine d-lactic and l-lactic acids in human serum of normal subjects and diabetic patients, showing that both d-lactic and l-lactic acid concentrations were significantly increased in the serum of diabetic patients ( n=31) as compared with normal subjects ( n=21). This fact was found for the first time owing to the development of the proposed HPLC method which is able to determine d-lactic and l-lactic acid simultaneously. Finally, serum d-lactic acid concentrations determined by the proposed HPLC method were compared with those from a reported enzymatic assay, and the smaller p value between normal subjects and diabetic patients was shown by the proposed HPLC method.
------>tmu_sno=None
------>sno=7538
------>authors2=None
------>authors3=None
------>authors4=None
------>authors5=None
------>authors6=None
------>authors6_c=None
------>authors=Hasegawa H., FukushimaT., Lee JA., Tsukamotoc K., Moriyad K., Onoe Y. and Imai K.*
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=None
------>publish_area=None
------>updateTitle=Determination of serum D-lactic and L-lactic acids in normal subjects and diabetic patients by column-switching HPLC with pre-column fluorescence derivatization.
------>language=2
------>check_flag=
------>submit_date=
------>country=None
------>no=5
------>patent_SDate=None
------>update_bywho=
------>publish_year=2003
------>submit_flag=
------>publish_month=None
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z